ES474149A1 - Un procedimiento para la produccion de un derivado de feni- letanolamina - Google Patents

Un procedimiento para la produccion de un derivado de feni- letanolamina

Info

Publication number
ES474149A1
ES474149A1 ES474149A ES474149A ES474149A1 ES 474149 A1 ES474149 A1 ES 474149A1 ES 474149 A ES474149 A ES 474149A ES 474149 A ES474149 A ES 474149A ES 474149 A1 ES474149 A1 ES 474149A1
Authority
ES
Spain
Prior art keywords
group
substituent
arylthio
aryloxy
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474149A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12203477A external-priority patent/JPS5473751A/ja
Priority claimed from JP12843677A external-priority patent/JPS5463048A/ja
Priority claimed from JP15535277A external-priority patent/JPS5495544A/ja
Priority claimed from JP7496478A external-priority patent/JPS552639A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES474149A1 publication Critical patent/ES474149A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento de producción de un derivado de feniletanolamina representada por la fórmula (* ver fórmula) donde R representa un átomo de hidrógeno, un átomo de halógeno, un grupo hidroxilo, un grupo alquilo inferior, un grupo alcoxi inferior, un grupo alquiltio inferior, un grupo amino, un grupo acilamino inferior, un grupo alquilsulfonilo inferior o un grupo alquilsulfonilamino inferior; R1, R2, R3 y R4, que puede ser iguales o diferentes, representan cada uno de ellos un átomo de hidrógeno o un grupo alquilo inferior; R5 representa un grupo arilo que puede contener sustituyentes, un grupo benzodioxano cíclico que pueden contener sustituyentes, un grupo ariloxi que puede contener sustituyentes o un grupo ariltio que puede contener sustituyentes; sin embargo, R5 es un grupo benzodioxano cíclico que puede contener sustituyentes, un grupo ariloxi que puede contener sustituyentes o un grupo ariltio que puede contener sustituyentes cuando R es un grupo hidroxilo y n es O o un número entero de 1 a 3.
ES474149A 1977-10-12 1978-10-11 Un procedimiento para la produccion de un derivado de feni- letanolamina Expired ES474149A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP12203477A JPS5473751A (en) 1977-10-12 1977-10-12 Phenyl ethanolamine derivatives and their preparation
JP12843677A JPS5463048A (en) 1977-10-26 1977-10-26 Novel phenyl ethanolamine derivatives and their preparation
JP15535277A JPS5495544A (en) 1977-12-23 1977-12-23 Phenylethanolamine derivative and its preparation
JP7496478A JPS552639A (en) 1978-06-21 1978-06-21 Phenylethanolamine derivative and its preparation

Publications (1)

Publication Number Publication Date
ES474149A1 true ES474149A1 (es) 1979-10-16

Family

ID=27465764

Family Applications (2)

Application Number Title Priority Date Filing Date
ES474149A Expired ES474149A1 (es) 1977-10-12 1978-10-11 Un procedimiento para la produccion de un derivado de feni- letanolamina
ES481549A Expired ES481549A1 (es) 1977-10-12 1979-06-13 Un procedimiento para la producicion de un derivado de feni-letanolamina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES481549A Expired ES481549A1 (es) 1977-10-12 1979-06-13 Un procedimiento para la producicion de un derivado de feni-letanolamina.

Country Status (16)

Country Link
US (1) US4217305A (es)
AT (1) AT363457B (es)
AU (1) AU526715B2 (es)
CA (1) CA1147342A (es)
CH (1) CH639948A5 (es)
DE (1) DE2843016A1 (es)
DK (1) DK168484B1 (es)
ES (2) ES474149A1 (es)
FR (1) FR2405931A1 (es)
GB (1) GB2006772B (es)
GR (1) GR65337B (es)
IT (1) IT1160853B (es)
NO (1) NO147148C (es)
PT (1) PT68624A (es)
SE (1) SE448232B (es)
SU (2) SU982537A3 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative
US4206125A (en) * 1979-05-04 1980-06-03 Richardson-Merrell Inc. 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives
DD157796A5 (de) * 1979-12-04 1982-12-08 Ciba Geigy Ag Verfahren zur herstellung neuer derivate des 2-amino-aethanols
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
EP0162404B1 (en) * 1984-05-15 1988-08-24 Seitetsu Kagaku Co., Ltd. Process for preparing 2-alkyl-5-haloacetylbenzenesulfonamide
US4678855A (en) * 1985-10-09 1987-07-07 Merck & Co., Inc. Substituted benzenesulfonamides
JPS62114952A (ja) * 1985-11-13 1987-05-26 Yamanouchi Pharmaceut Co Ltd 置換フエネチルアミン誘導体の製造法
EP0317206B1 (en) * 1987-11-13 1993-04-28 Glaxo Group Limited Phenethanolamine derivatives
ES2137260T3 (es) * 1992-05-22 1999-12-16 Senju Pharma Co Composicion farmaceutica para uso en el tratamiento del glaucoma.
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
AU715233B2 (en) * 1996-01-10 2000-01-20 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
WO1999057131A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
FR2791675B1 (fr) * 1999-03-30 2001-05-04 Synthelabo Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
US6835853B2 (en) * 2001-10-31 2004-12-28 Synthon Bv Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
GEP20084406B (en) 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
WO2005056521A1 (en) * 2003-12-09 2005-06-23 Cj Corporation Method of preparing optically pure phenethylamine derivatives
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
CN102050766B (zh) * 2009-11-03 2013-08-07 安徽省新星药物开发有限责任公司 一种盐酸氨磺洛尔的合成方法
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
GB1266058A (es) 1969-07-08 1972-03-08
GB1321701A (en) 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
US4034112A (en) * 1973-06-22 1977-07-05 Imperial Chemical Industries Limited Ethanolamine derivatives having β-adrenergic blocking activity
US3860647A (en) * 1973-08-20 1975-01-14 Smithkline Corp {60 -Aminomethyl-4-hydroxy-3-sulfamyl-benzyl alcohols and 4-hydroxy-3-sulfamyl phenethylamines
GB1593651A (en) * 1977-02-03 1981-07-22 Allen & Hanburys Ltd Amides
DK31578A (da) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af benzenderivater

Also Published As

Publication number Publication date
US4217305A (en) 1980-08-12
CA1147342A (en) 1983-05-31
NO147148B (no) 1982-11-01
SU982537A3 (ru) 1982-12-15
IT1160853B (it) 1987-03-11
AU4064278A (en) 1980-04-17
SE7810613L (sv) 1979-04-13
AU526715B2 (en) 1983-01-27
GB2006772B (en) 1982-02-03
GB2006772A (en) 1979-05-10
DK452178A (da) 1979-04-13
FR2405931A1 (fr) 1979-05-11
NO147148C (no) 1983-02-09
AT363457B (de) 1981-08-10
DE2843016C2 (es) 1988-10-13
SU932982A3 (ru) 1982-05-30
DE2843016A1 (de) 1979-04-26
NO783442L (no) 1979-04-18
SE448232B (sv) 1987-02-02
DK168484B1 (da) 1994-04-05
FR2405931B1 (es) 1982-11-19
CH639948A5 (de) 1983-12-15
IT7869350A0 (it) 1978-10-11
PT68624A (en) 1978-11-01
GR65337B (en) 1980-08-18
ES481549A1 (es) 1980-04-01
ATA731778A (de) 1981-01-15

Similar Documents

Publication Publication Date Title
ES481549A1 (es) Un procedimiento para la producicion de un derivado de feni-letanolamina.
AU565870B2 (en) N-heterocyclylsulphonyl-n:-pyrimidinyl (and thiazinyl)-ureas
SE429651B (sv) Forfarande for framstellning av alfa-fenylbensylidenaminosyraderivat med antikonvulsiv aktivitet
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
ES440426A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES8105976A1 (es) Procedimiento para la preparacion de acilureas
ATE33133T1 (de) Alpha-alkyl-polyencarbonsaeuren, ihre derivate und ihre verwendung in der behandlung von psoriasis.
FI800224A (fi) 2-hydroxi-naftalinderivat och anvaendningen av dessa som kopplingskomponenter i diazotypiefieringsmaterial
DK146688C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2)
ATE22290T1 (de) Antihypertensive laktame.
DK256982A (da) Fremgangsmaade til fremstilling af n-phthalidyl-5-flyoruracilderivater
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
ES8303438A1 (es) Un procedimiento para la preparacion de perfluoroamidas
ES8801542A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
ES8606245A1 (es) Procedimiento para preparar fenoxianilinas y piridiloxianilinas sustituidas
ATE189813T1 (de) Prostaglandin-i-analoga
SE7708184L (sv) Nya acetofenonderivat och sett for deras framstellning
ES458283A1 (es) Procedimiento para preparar pirimidinas difosforiladas.
FR2312255B1 (es)
GB1102476A (en) Benzodioxane derivatives
AR241163A2 (es) Procedimiento para obtener derivados de chartreusina y compuestos intermediarios de aplicacion exclusiva en dicho procedimiento
GB2000143A (en) Phosphorins-containing pyrimidine derivates having insecticidal properties

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204